Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 191, Supplement 658
Joint Meeting of The Slovak Physiological Society, The Physiological Society and The Federation of European Physiological Societies
9/11/2007-9/14/2007
Bratislava, Slovakia


THE EFFECT OF DIABETES MELLITUS ON MYOCARDIAL RESISTANCE TO ISCHAEMIA/ REPERFUSION INJURY AND PPAR EXPRESSION IN THE RAT HEART
Abstract number: OTH13-49

Ravingerova1 T., Adameova2 A., Kelly3 T., Antonopoulou3 E., Matejikova1 J., Kuzelova2 M., Svec2 P., Lazou3 A.

1Inst Heart Res SAS
2Dept Pharmacol Toxicol, Fac Pharm Comenius Univ, Bratislava, Slovakia
3School Biol., Aristotle Univ., Thessaloniki, Greece

Aims: 

The study was aimed to explore the effect of diabetes mellitus (DM) on the expression of PPAR isoforms (key transcriptional regulators of lipid metabolism and energy production) and their role in myocardial ischaemia/ reperfusion injury (I/R).

Methods: 

In the Langendorff-perfused hearts of rats with 5-day DM (STZ) and the controls (C) subjected to 30-min LAD occlusion and 2-h reperfusion, were measured mRNA expression (RT-PCR) of alpha, beta and gamma isoforms of PPAR before and after I/R and infarction size (IS; TTZ).

Results: 

Baseline levels of PPAR isoforms were significantly increased in the DM group as compared with C. Marked down-regulation of all three isoforms following I/R in C was attenuated in diabetics, and PPAR alpha was even significantly increased. IS normalized to the area at risk (AR) size was significantly lower in DM group as compared with C (IS/AR 15.1 ± 3.0%vs. 37.3 ± 3.1%; P < 0.05).

Conclusions: 

Increased expression of PPAR might reflect changes in lipid metabolism induced by DM. On the other hand, maintained levels of PPAR isoforms after I/R might indicate their role in higher cardiac resistance to I/R in the acute phase of DM. Grants UK19/2007, 2/5110/25, MVTS SR-GR 15, APVT-51-027404, GSRT- 759 5190/2005.

GroupsPPAR alpha/GAPDHPPAR beta/GAPDHPPAR gamma/GAPDH
C0.156 ± 0.0150.056 ± 0.0030.180 ± 0.010
I/R0.097 ± 0.010†0.028 ± 0.010†0.122 ± 0.016†
DM0.186 ± 0.019*0.094 ± 0.015*0.205 ± 0.014*
DM+I/R0.232 ± 0.046*†0.072 ± 0.014*0.210 ± 0.031
*-p < 0.05 vs. non-diabetics, †-p < 0.05 vs. baseline

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 191, Supplement 658 :OTH13-49

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE